Aarti Drugs Limited (NSE:AARTIDRUGS)

Aarti Drugs Revenue

Aarti Drugs had revenue of 8.26B INR in the quarter ending September 30, 2026, with 26.57% growth. This brings the company's total for the last twelve months to 28.51B, up 15.12% year-over-year. In the fiscal year ending March 31, 2026, Aarti Drugs had annual revenue of 25.65B with 7.47% growth.

• Revenue (ttm): 28.51B
• Revenue Growth: +15.12%
• P/S Ratio: 1.60
• Revenue / Employee: 21.04M
• Employees: 1,355
• Market Cap: 45.08B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• India 15.69B 61.2%
• Out of India 9.96B 38.8%

Fiscal year ended Mar 31, 2026 See the full Aarti Drugs breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	25.65B	1.78B	7.47%
Mar 31, 2025	23.87B	-1.42B	-5.60%
Mar 31, 2024	25.29B	-1.87B	-6.90%
Mar 31, 2023	27.16B	2.27B	9.14%
Mar 31, 2022	24.89B	3.34B	15.49%

Data Source: S&P Global Market Intelligence Last updated: Nov 3, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error